PD, do you know when the ASCO abstract was submitted? I never would have expected the company to report on the stage 2 patients until they had at least 8 weeks of data for the entire group (which would be late June/early July at best). That would be consistent with what they've been doing thus far. But, after reading the abstract, it sounded like they were planning to release the preliminary results for stage II during ASCO. If the abstract was submitted back in January, that would explain the lack of news. Last December King indicated that they felt the stage 2 enrollment would be done around the end of the first quarter, so if the abstract was created in January they probably thought they would have 8 weeks of data from the second group by now.
Market Data 
Markets 
AI
